• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

42 年间腮腺恶性肿瘤的发病率和生存趋势。

Incidence and survival trends of parotid malignancies over 42 years.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.

出版信息

Head Neck. 2020 Sep;42(9):2308-2315. doi: 10.1002/hed.26172. Epub 2020 Apr 21.

DOI:10.1002/hed.26172
PMID:32314846
Abstract

BACKGROUND

There is a paucity of information regarding the incidence and survival of parotid malignancies over time.

METHODS

The Surveillance, Epidemiology, and End Results population-based cancer registry was queried for parotid malignancies from 1973 to 2015.

RESULTS

The age-adjusted incidence of parotid malignancies has increased by 58.1% (7.87-12.44 per 1 000 000). Analysis of histologic type revealed an increased annual percent change (APC) of acinar cell carcinoma (1.38) and squamous cell carcinoma (1.58), but decreased APC of adenoid cystic carcinoma (-1.63) and adenocarcinoma NOS (-0.86) (P < .05). The disease-specific survival of mucoepidermoid carcinoma, adenocarcinoma NOS, and squamous cell carcinoma significantly improved (P < .05) over time.

CONCLUSION

The incidence of parotid cancer is rising steadily since 1973, while the incidence of overall head and neck cancer has decreased. Further research is necessary to understand the etiology, risk factors, and pathophysiology of parotid cancer to curb its rising incidence.

LEVEL OF EVIDENCE

摘要

背景

关于腮腺恶性肿瘤随时间推移的发病率和生存率的信息较少。

方法

通过监测、流行病学和最终结果(SEER)基于人群的癌症登记处,从 1973 年到 2015 年对腮腺恶性肿瘤进行了查询。

结果

年龄调整后的腮腺恶性肿瘤发病率增加了 58.1%(7.87-12.44/100 万)。对组织学类型的分析显示,腺泡细胞癌(1.38)和鳞状细胞癌(1.58)的年百分比变化率(APC)增加,但腺样囊性癌(-1.63)和腺癌 NOS(-0.86)的 APC 降低(P<.05)。黏液表皮样癌、腺癌 NOS 和鳞状细胞癌的疾病特异性生存率随时间显著改善(P<.05)。

结论

自 1973 年以来,腮腺癌的发病率一直在稳步上升,而头颈部癌症的总体发病率却在下降。需要进一步研究以了解腮腺癌的病因、危险因素和病理生理学,以遏制其发病率的上升。

证据水平

4 级

相似文献

1
Incidence and survival trends of parotid malignancies over 42 years.42 年间腮腺恶性肿瘤的发病率和生存趋势。
Head Neck. 2020 Sep;42(9):2308-2315. doi: 10.1002/hed.26172. Epub 2020 Apr 21.
2
Tumors in the parotid are not relatively more often malignant in children than in adults.腮腺肿瘤在儿童中恶变的几率并不比成人相对更高。
Int J Pediatr Otorhinolaryngol. 2015 Aug;79(8):1192-5. doi: 10.1016/j.ijporl.2015.04.035. Epub 2015 Apr 29.
3
Heterogeneous impact of smoking on major salivary gland cancer according to histopathological subtype: A case-control study.根据组织病理学亚型分析吸烟对大唾液腺癌的异质性影响:一项病例对照研究。
Cancer. 2018 Jan 1;124(1):118-124. doi: 10.1002/cncr.30957. Epub 2017 Sep 7.
4
Clinical features and prognostic factors for malignant parotid tumors in children and adolescents: A population-based study.儿童和青少年腮腺恶性肿瘤的临床特征和预后因素:基于人群的研究。
J Stomatol Oral Maxillofac Surg. 2024 Sep;125(4):101741. doi: 10.1016/j.jormas.2023.101741. Epub 2023 Dec 15.
5
Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA).丹麦 1990-2005 年唾液腺癌:一项全国性的发病率、部位和组织学研究。丹麦头颈部癌症研究组(DAHANCA)的研究结果。
Oral Oncol. 2011 Jul;47(7):677-82. doi: 10.1016/j.oraloncology.2011.04.020. Epub 2011 May 25.
6
Patterns of lymph node metastasis of parotid cancer.腮腺癌的淋巴结转移模式。
Auris Nasus Larynx. 2016 Aug;43(4):446-50. doi: 10.1016/j.anl.2015.11.002. Epub 2015 Dec 4.
7
Salivary gland tumours in Iceland 1986-2015: a nationwide epidemiological analysis over a 30-year time period.冰岛 1986-2015 年唾液腺肿瘤:30 年时间内的全国性流行病学分析。
APMIS. 2021 Feb;129(2):55-60. doi: 10.1111/apm.13090. Epub 2020 Nov 3.
8
Malignant tumors of the parotid gland in children: incidence and outcomes.儿童腮腺恶性肿瘤:发病率与预后
J Craniofac Surg. 2013 Sep;24(5):1660-4. doi: 10.1097/SCS.0b013e3182997d52.
9
Incidence of salivary gland neoplasms in a defined UK population.英国特定人群中唾液腺肿瘤的发病率。
Br J Oral Maxillofac Surg. 2013 Jul;51(5):399-403. doi: 10.1016/j.bjoms.2012.10.002. Epub 2012 Oct 24.
10
Twenty-seven years of primary salivary gland carcinoma in Wales: an analysis of histological subtype and associated risk factors.威尔士原发性唾液腺癌 27 年回顾:组织学亚型与相关危险因素分析。
J Laryngol Otol. 2022 Feb;136(2):167-172. doi: 10.1017/S002221512200007X. Epub 2022 Jan 10.

引用本文的文献

1
[Clinical and molecular epidemiology of malignant salivary gland tumors].[涎腺恶性肿瘤的临床与分子流行病学]
Laryngorhinootologie. 2025 Feb;104(2):87-93. doi: 10.1055/a-2373-5741. Epub 2024 Oct 17.
2
Systematic Review of Management and Survival Outcome of Parotid Cancers with Lateral Skull Base Invasion.伴有侧颅底侵犯的腮腺癌管理及生存结果的系统评价
Indian J Otolaryngol Head Neck Surg. 2023 Sep;75(3):2713-2721. doi: 10.1007/s12070-023-03787-1. Epub 2023 May 3.
3
Epidemiology of and factors associated with overall survival for patients with head and neck adenoid cystic carcinoma.
头颈部腺样囊性癌患者的总体生存率及其相关因素的流行病学研究
J Cancer Res Clin Oncol. 2023 Nov;149(15):14071-14080. doi: 10.1007/s00432-023-05224-w. Epub 2023 Aug 7.
4
Incidence and clinical outcome of primary carcinomas of the major salivary glands: 10-year data from a population-based state cancer registry in Germany.主要涎腺原发性癌的发病率和临床结局:德国一个基于人群的州癌症登记处的 10 年数据。
J Cancer Res Clin Oncol. 2023 Jul;149(7):3811-3821. doi: 10.1007/s00432-022-04278-6. Epub 2022 Aug 22.
5
Acinic cell carcinoma of the parotid gland: Timeo Danaos et dona ferentes? A multicenter retrospective analysis focusing on survival outcome.腮腺的闰管细胞癌:畏惧 Danaos 及其带来的礼物?一项关注生存结局的多中心回顾性分析。
Eur Arch Otorhinolaryngol. 2022 Dec;279(12):5821-5829. doi: 10.1007/s00405-022-07481-w. Epub 2022 Jun 9.
6
Salivary gland function, development, and regeneration.唾液腺功能、发育和再生。
Physiol Rev. 2022 Jul 1;102(3):1495-1552. doi: 10.1152/physrev.00015.2021. Epub 2022 Mar 28.
7
Trends in the incidence of head and neck cancer by subsite between 1993 and 2015 in Japan.日本 1993 年至 2015 年间头颈部癌症各部位发病率的变化趋势。
Cancer Med. 2022 Mar;11(6):1553-1560. doi: 10.1002/cam4.4539. Epub 2022 Jan 14.
8
Adjuvant radiotherapy in malignant tumors of parotid. Experience of the Navarra Hospital Complex.腮腺恶性肿瘤的辅助放疗。纳瓦拉医院联合体的经验。
Rep Pract Oncol Radiother. 2021 Dec 30;26(6):962-967. doi: 10.5603/RPOR.a2021.0118. eCollection 2021.